Q2 2009

Source filing unavailable

Q2 2009 · —

Revenue

$5.84M

no prior Q2 2008 on file

Net Income

-$283.00K

no prior Q2 2008 on file

EPS Diluted

-$0.01

no prior Q2 2008 on file

Operating Income-$3,628,000—

Margins · derived

Operating margin-62.1%

Net margin-4.8%

Same quarter

no prior Q2 2008 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Ligand Pharmaceuticals Inc · CIK 886163 · Engraved from SEC EDGAR